1 year return (CAGR)
109.25%
Enliven Therapeutics Inc. Exchange (NASDAQ, USD)
ELVN
44.25
+1.09 (+2.49%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
51.81%
5 year return (CAGR)
-5.07%
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
3.28B
Price/Sales
-
Ent value
3.16B
Price/Book
3.67
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-9.23%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 43.69 |
| Daily high | 44.94 |
| Daily low | 43.39 |
| Daily Volume | 1.26M |
| All-time high | 877.92 |
| 1y analyst estimate | 73.67 |
| Beta | 0.24 |
| EPS (TTM) | -1.60 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 12 Mar 2026 |
Downside potential
Loading...
Downside potential data
| ELVN | S&P500 | |
| Current price drop from All-time high | -94.96% | -3.00% |
| Highest price drop | -98.85% | -56.47% |
| Date of highest drop | 12 Dec 2023 | 9 Mar 2009 |
| Avg drop from high | -88.42% | -10.65% |
| Avg time to new high | 83 days | 12 days |
| Max time to new high | 1604 days | 1805 days |
News
